Welcome to the Most Comprehensive Forum for Microbiome-Targeting Drug Developers

The study of the human microbiome remains one of the most exciting frontiers in modern medicine that if targeted correctly, has the potential to benefit millions of patients suffering from numerous diseases. However, the potential for effective medicines powered by the microbiome is matched by the unique challenges in developing them. The Microbiome Movement – Drug Development Summit returns as the "must attend meeting for the translational microbiome community" to help cutting-edge pharmaceutical and academic researchers pursue the causal role of the human microbiome in disease to help deliver a new generation of targeted therapeutics, biomarker and diagnostics that demonstrate consistent clinical outcomes and predictabe MoAs.

So whether you’re part of a microbiome-focused biotech, a pharmaceutical organization assessing this exciting field, or an academic researcher with breakthrough findings, join the Microbiome Movement as we explore the global advances in translational microbiome research, and meet like-minded peers who are continuing to understand the causal and therapeutic potential of the 'second genome'.

Access the official 2020 agenda to see the topics that will be addressed.

4 Areas that Define the Drug Development Summit

Pre-Clinical Development & Mechanisms of Microbiome-based Therapeutics

Clinical Development, Manufacturing & Commercialization of Microbiome-based Therapeutics 

Microbiome Biomarkers, Diagnostics & Patient Stratification 

 

Pre-Conference Oncology Day 

Learn how leaders in the field are developing novel microbiome platforms to identify new targets and therapeutics across a range of modalities and disease phenotypes.

As the industry matures, navigate through the translational, clinical and manufacturing challenges to help improve clinical outcomes and develop these treatments

Mine the human microbiome to discover new biomarkers of disease and help predict response, understand drug metabolism and develop noninvasive diagnostic tools

Gain a comprehensive insight into the most exciting disease target in microbiome research today with case-studies and discussion from leading cancer centers, oncology-specific clinicians and the pharmaceutical industry.

Hear What Our Attendees Say

"This is far and away the best of the microbiome therapeutics conferences I’ve attended. Always up to date, relevant topics, and speakers from a wide range of companies. The networking opportunities alone are fantastic”

Julius Goepp, CEO, Scaled Microbiomics 

“The Microbiome Movement – Drug Development Summit is probably the most important meeting to attend for anyone involved in microbiome drug development

Julie Schwedock, CMC Associate Scientific Fellow, Takeda